Clinical Trial

Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

Study acronym: SCA FA
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Patients with Acute Coronary Syndrome associated with de novo atrial fibrillation are randomized to benefit from either a conventional therapy associating dual antiplatelet therapy (DAPT) and anticoagulant or DAPT and an implantable monitoring device with a follow-up by telecardiology
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-02-18; most recent amendment 2026-03-19.
Status change: Recruiting → Active, Not Recruiting 2026-03-19
Status change: Not Yet Recruiting → Recruiting 2021-07-27
Trial Details
NCT Number NCT04276155
Lead Sponsor Centre Hospitalier de PAU
Conditions Atrial Fibrillation, Myocardial Infarction
Enrollment 500 participants
Start Date 2021-08-03
Primary Completion 2027-06-22 (estimated)
Study Completion 2027-06-22 (estimated)
Updated on ClinicalTrials.gov 2026-03-23